TOP > 外国特許検索 > COLORECTAL CANCER DIAGNOSTIC MARKER, METHOD FOR ASSISTING DIAGNOSIS OF COLORECTAL CANCER, METHOD FOR COLLECTING DATA FOR DIAGNOSIS OF COLORECTAL CANCER, COLORECTAL CANCER DIAGNOSTIC KIT, THERAPEUTIC AGENT FOR COLORECTAL CANCER, METHOD FOR TREATING COLORECTAL CANCER, AND METHOD FOR DIAGNOSING COLORECTAL CANCER

COLORECTAL CANCER DIAGNOSTIC MARKER, METHOD FOR ASSISTING DIAGNOSIS OF COLORECTAL CANCER, METHOD FOR COLLECTING DATA FOR DIAGNOSIS OF COLORECTAL CANCER, COLORECTAL CANCER DIAGNOSTIC KIT, THERAPEUTIC AGENT FOR COLORECTAL CANCER, METHOD FOR TREATING COLORECTAL CANCER, AND METHOD FOR DIAGNOSING COLORECTAL CANCER

外国特許コード F210010361
整理番号 (S2019-0533-N0)
掲載日 2021年4月26日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2020JP030676
国際公開番号 WO 2021033605
国際出願日 令和2年8月12日(2020.8.12)
国際公開日 令和3年2月25日(2021.2.25)
優先権データ
  • 特願2019-149338 (2019.8.16) JP
発明の名称 (英語) COLORECTAL CANCER DIAGNOSTIC MARKER, METHOD FOR ASSISTING DIAGNOSIS OF COLORECTAL CANCER, METHOD FOR COLLECTING DATA FOR DIAGNOSIS OF COLORECTAL CANCER, COLORECTAL CANCER DIAGNOSTIC KIT, THERAPEUTIC AGENT FOR COLORECTAL CANCER, METHOD FOR TREATING COLORECTAL CANCER, AND METHOD FOR DIAGNOSING COLORECTAL CANCER
発明の概要(英語) The present invention provides: a colorectal cancer diagnostic marker which can determine the presence or absence of colorectal cancer morbidity with high accuracy and which can also detect early colorectal cancer with high sensitivity; a method which is for assisting the diagnosis of colorectal cancer, and measures the expression level of the colorectal cancer diagnostic marker, a method for collecting data to diagnose colorectal cancer, a method for diagnosing colorectal cancer; a method for treating colorectal cancer; a colorectal cancer diagnostic kit including the colorectal cancer diagnostic marker and a specific primer; and a therapeutic agent containing an inhibitor of the colorectal cancer diagnostic marker. The colorectal cancer diagnostic marker according to the present invention is at least one microRNA selected from the group consisting of hsa-miR-129-1-3p, hsa-miR-566, and hsa-miR-598-5p.
従来技術、競合技術の概要(英語) BACKGROUND ART
Lower gastrointestinal endoscopy and fecal heath testing are known as methods for examining the presence or absence of colon cancer (for example, Non-Patent Documents 1 and 2). Lower gastrointestinal endoscopy takes longer to examine, is highly invasive, and also costly to examine. Therefore, lower gastrointestinal endoscopy is not recommended for medical examinations and screening tests for healthy individuals. As a result of the above, fecal latent blood tests are often performed in the examination of colon cancer or the like. In addition, CEA (carcinoembryonicantigen) and CA19-9 (carbohydrate antigen 19-9) are known as biomarkers for colon cancer.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • NAGOYA CITY UNIVERSITY
  • 発明者(英語)
  • SHIMURA Takaya
  • IWASAKI Hiroyasu
  • KATAOKA Hiromi
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DJ DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS IT JO JP KE KG KH KN KP KR KW KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN WS ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
ライセンスをご希望の方、特許の内容に興味を持たれた方は、問合せボタンを押してください。

PAGE TOP

close
close
close
close
close
close